We hypothesized the Notch1 gene as a therapeutic target by using miR-34a to knock down its expression, thereby inducing Bcl-2/Caspase-3 signaling pathway mediated apoptosis and inhibiting the growth of ovarian cancer. The gene discussed is NOTCH1; the disease is ovarian cancer.